Form 8-K - Current report:
SEC Accession No. 0001847903-25-000093
Filing Date
2025-06-20
Accepted
2025-06-20 16:09:40
Documents
13
Period of Report
2025-06-20
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K cnta-20250620.htm   iXBRL 8-K 47248
  Complete submission text file 0001847903-25-000093.txt   220377

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cnta-20250620.xsd EX-101.SCH 2616
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cnta-20250620_def.xml EX-101.DEF 16868
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cnta-20250620_lab.xml EX-101.LAB 30840
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cnta-20250620_pre.xml EX-101.PRE 18275
15 EXTRACTED XBRL INSTANCE DOCUMENT cnta-20250620_htm.xml XML 4497
Mailing Address 3RD FLOOR 1 ASHLEY ROAD ALTRINCHAM, CHESHIRE X0 WA14 2DT
Business Address 3RD FLOOR 1 ASHLEY ROAD ALTRINCHAM, CHESHIRE X0 WA14 2DT 44 7391 789784
Centessa Pharmaceuticals plc (Filer) CIK: 0001847903 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40445 | Film No.: 251061422
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)